Net loss of Aspira Pathlab & Diagnostics reported to Rs 1.56 crore in the quarter ended December 2025 as against net profit of Rs 0.38 crore during the previous quarter ended December 2024. Sales declined 5.36% to Rs 5.12 crore in the quarter ended December 2025 as against Rs 5.41 crore during the previous quarter ended December 2024. ParticularsQuarter EndedDec. 2025Dec. 2024% Var. Sales5.125.41 -5 OPM %-23.6314.23 - PBDT-1.180.77 PL PBT-1.560.38 PL NP-1.560.38 PL Powered by Capital Market - Live News

Aspira Pathlab & Diagnostics will hold a meeting of the Board of Directors of the Company on 10 February 2026.Powered by Capital Market - Live News

Net profit of Aspira Pathlab & Diagnostics rose 85.86% to Rs 1.84 crore in the quarter ended September 2025 as against Rs 0.99 crore during the previous quarter ended September 2024. Sales rose 30.91% to Rs 8.09 crore in the quarter ended September 2025 as against Rs 6.18 crore during the previous quarter ended September 2024. ParticularsQuarter EndedSep. 2025Sep. 2024% Var. Sales8.096.18 31 OPM %27.1921.84 - PBDT2.241.35 66 PBT1.840.99 86 NP1.840.99 86 Powered by Capital Market - Live News

Aspira Pathlab & Diagnostics will hold a meeting of the Board of Directors of the Company on 12 November 2025.Powered by Capital Market - Live News

Aspira Pathlab & Diagnostics announced that the 52th Annual General Meeting(AGM) of the company will be held on 26 September 2025.Powered by Capital Market - Live News